nexterone (amiodarone hci)
Generic: nexterone (amiodarone hci)
Labeler: hf acquisition co llc, dba healthfirstDrug Facts
Product Profile
Brand Name
nexterone (amiodarone hci)
Generic Name
nexterone (amiodarone hci)
Labeler
hf acquisition co llc, dba healthfirst
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
amiodarone hydrochloride 1.5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51662-1480
Product ID
51662-1480_11c3bf02-6616-9353-e063-6394a90af9cd
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA022325
Listing Expiration
2026-12-31
Marketing Start
2020-01-29
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516621480
Hyphenated Format
51662-1480
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
nexterone (amiodarone hci) (source: ndc)
Generic Name
nexterone (amiodarone hci) (source: ndc)
Application Number
NDA022325 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1.5 mg/mL
Packaging
- 1 BAG in 1 CARTON (51662-1480-1) / 100 mL in 1 BAG
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "11c3bf02-6616-9353-e063-6394a90af9cd", "openfda": {"unii": ["976728SY6Z"], "rxcui": ["849876", "1046406"], "spl_set_id": ["9d4d66f7-fa14-e832-e053-2a95a90a8b62"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BAG in 1 CARTON (51662-1480-1) / 100 mL in 1 BAG", "package_ndc": "51662-1480-1", "marketing_start_date": "20200129"}], "brand_name": "NEXTERONE (AMIODARONE HCI)", "product_id": "51662-1480_11c3bf02-6616-9353-e063-6394a90af9cd", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antiarrhythmic [EPC]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1480", "generic_name": "NEXTERONE (AMIODARONE HCI)", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NEXTERONE (AMIODARONE HCI)", "active_ingredients": [{"name": "AMIODARONE HYDROCHLORIDE", "strength": "1.5 mg/mL"}], "application_number": "NDA022325", "marketing_category": "NDA", "marketing_start_date": "20200129", "listing_expiration_date": "20261231"}